Stoke Therapeutics (STOK)
(Delayed Data from NSDQ)
$11.69 USD
+0.03 (0.26%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $11.68 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.60 | 0.00% |
Earnings Summary
For their last quarter, Stoke Therapeutics (STOK) reported earnings of -$0.60 per share, beating the Zacks Consensus Estimate of $-0.62 per share. This reflects a positive earnings surprise of 3.23%. Look out for STOK's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.60 per share, reflecting a year-over-year decrease of 13.21%.
Earnings History
Price & Consensus
Zacks News for STOK
Stoke Therapeutics (STOK) Up on Upbeat Dravet Syndrome Study Data
STOK: What are Zacks experts saying now?
Zacks Private Portfolio Services